CS 1103
Alternative Names: CS-1103Latest Information Update: 22 Apr 2024
At a glance
- Originator Clear Scientific
- Developer Clear Scientific; National Institute of Drug Abuse
- Class Drug withdrawal therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Substance-related disorders